Organisation paid for research Program year 2023 Source: CMS Open Payments

Advanced Cardiovascular Specialists

Neither a doctor nor a teaching hospital

Research payments

$57,184

46 payments

Through program year 2023, Advanced Cardiovascular Specialists is reported as receiving $57,184 in research payments, across 46 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2023	Research	$8,606	7
2022	Research	$14,944	10
2021	Research	$7,361	7
2020	Research	$11,471	7
2019	Research	$14,802	15

Breakdown

Who paid Research payments · program years 2019–2023

Boston Scientific Corporation $26,794 19 payments
Medtronic, Inc. $22,671 17 payments
AstraZeneca Pharmaceuticals LP $4,300 1 payment
Medtronic Vascular, Inc. $2,021 2 payments
Endologix, Inc. $975 1 payment
Abbott Laboratories $341 4 payments
Amgen Inc. $82 2 payments

Studies the money was for Research payments · program years 2019–2023

Longevity Study $26,794 19 payments
Psr-Cvg $21,075 13 payments
Affordability and Real world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study Current patterns of P2Y12 receptor inhibitor use provide an excellent opportunity to test the impact of copayment reduction on clinician choice of medication patient adherence and clinical outcomes $4,300 1 payment
ECG Belt $2,021 2 payments
Alleviate-Hf $1,596 4 payments
Detour II Study $975 1 payment
Hemodynamic Guided Monitoring in Heart Failure (HF) Trial (GUIDE-HF) $341 4 payments
Galactic-Hf $77 1 payment
Galactic - HF $5 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.